Deciphera Pharmaceuticals Inc DCPH:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/15/24 EDT
25.45quote price arrow up+0.01 (+0.04%)
Volume
937,757
52 week range
9.90 - 25.55
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close25.45
  • 52 Week High25.55
  • 52 Week High Date05/10/24
  • 52 Week Low9.90
  • 52 Week Low Date10/25/23

Key Stats

  • Market Cap2.201B
  • Shares Out86.48M
  • 10 Day Average Volume2.48M
  • Dividend-
  • Dividend Yield-
  • Beta0.19
  • YTD % Change57.78

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close25.45
  • 52 Week High25.55
  • 52 Week High Date05/10/24
  • 52 Week Low9.90
  • 52 Week Low Date10/25/23
  • Market Cap2.201B
  • Shares Out86.48M
  • 10 Day Average Volume2.48M
  • Dividend-
  • Dividend Yield-
  • Beta0.19
  • YTD % Change57.78

RATIOS/PROFITABILITY

  • EPS (TTM)-2.21
  • P/E (TTM)-11.52
  • Fwd P/E (NTM)-11.89
  • EBITDA (TTM)-204.606M
  • ROE (TTM)-50.37%
  • Revenue (TTM)174.91M
  • Gross Margin (TTM)96.95%
  • Net Margin (TTM)-108.87%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date06/03/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Deciphera Pharmaceuticals Inc

 

Profile

MORE
Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing new medicines to improve the lives of people with cancer. The Company is leveraging its switch-control kinase inhibitor platform in kinase biology to develop a portfolio of medicines. The Company's QINLOCK, is a switch-control kinase inhibitor, engineered using its drug discovery platform and developed for the treatment of fourth-line gastrointestinal stromal...
Ron Squarer
Independent Chairman of the Board
Steven Hoerter
President, Chief Executive Officer, Director
Thomas Kelly J.D.
Chief Financial Officer, Executive Vice President, Treasurer
Dashyant Dhanak Ph.D.
Executive Vice President, Chief Scientific Officer
Matthew Sherman M.D.
Executive Vice President, Chief Medical Officer
Address
200 Smith St
Waltham, MA
02451-0099
United States

Top Peers

SYMBOLLASTCHG%CHG
VCEL
Vericel Corp
49.41+0.88+1.81%
ARDX
Ardelyx Inc
7.85+0.06+0.77%
ARVN
Arvinas Inc
32.33+0.97+3.09%
RYTM
Rhythm Pharmaceuticals Inc
39.60-0.78-1.93%
KYMR
Kymera Therapeutics Inc
35.94+0.85+2.42%